reference/4308405

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/4308405

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, P.H.S.
endingPage	810
issn	0022-1007 1540-9538
issueIdentifier	7
pageRange	801-810
publicationName	The Journal of Experimental Medicine
startingPage	801
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_8e696e623b7822b80109521a53031ba7 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_199db1bef4b0308c0639203aa0befa4f
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d5bca0efeb93f828aac03ba374b35958 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f5bdc0e48cf62b6a13d3c983f652a89b
bibliographicCitation	Arbour N, Naniche D, Homann D, Davis RJ, Flavell RA, Oldstone MB. c-Jun NH(2)-terminal kinase (JNK)1 and JNK2 signaling pathways have divergent roles in CD8(+) T cell-mediated antiviral immunity. J Exp Med. 2002 Apr 01;195(7):801–10. PMID: 11927625; PMCID: PMC2193720.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e4744447014920d0bd81e44b782ee316 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5268415e55d3a93e35cd1afd3cc7d87b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_74f15c60ce8d6e623318ab1379b9c1e4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_913b07c1cbadb301aa39d25fe8e916d4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ceafa73563da5239fb1273c53836783a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9d24d3bda4dcd09c2218d9fcf6308968 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3718-1584
date	2002-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1084/jem.20011481 https://pubmed.ncbi.nlm.nih.gov/PMC2193720 https://pubmed.ncbi.nlm.nih.gov/11927625
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4724 https://portal.issn.org/resource/ISSN/0022-1007 https://portal.issn.org/resource/ISSN/1540-9538
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	c-Jun NH(2)-terminal kinase (JNK)1 and JNK2 signaling pathways have divergent roles in CD8(+) T cell-mediated antiviral immunity
discusses	http://id.nlm.nih.gov/mesh/M0328039 http://id.nlm.nih.gov/mesh/M0362611 http://id.nlm.nih.gov/mesh/M0239058 http://id.nlm.nih.gov/mesh/M0011506 http://id.nlm.nih.gov/mesh/M0011490
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D008217Q000502 http://id.nlm.nih.gov/mesh/D020928Q000378 http://id.nlm.nih.gov/mesh/D008216Q000276 http://id.nlm.nih.gov/mesh/D018414Q000276 http://id.nlm.nih.gov/mesh/D014780Q000276 http://id.nlm.nih.gov/mesh/D020935Q000276
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D020022 http://id.nlm.nih.gov/mesh/D007109 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D015496Q000276 http://id.nlm.nih.gov/mesh/D007371Q000494 http://id.nlm.nih.gov/mesh/D048056 http://id.nlm.nih.gov/mesh/D006377Q000276 http://id.nlm.nih.gov/mesh/D048055 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D013154Q000276 http://id.nlm.nih.gov/mesh/D013154Q000187 http://id.nlm.nih.gov/mesh/D018345 http://id.nlm.nih.gov/mesh/D007376Q000494 http://id.nlm.nih.gov/mesh/D018414Q000821 http://id.nlm.nih.gov/mesh/D020928Q000172 http://id.nlm.nih.gov/mesh/D020928Q000235
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6d2eac63192f2d6e4b9b95cd225e2ba7 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_07edfd5399a4297179b0eb6e7ec0142a http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9f919c7f37a7b148a0375d1c8979253c http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_29f84c0d894769b14b36c5f43f54153e http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9601 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b4d4b7e05ee155ea36becc2fb2ac8284 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6b5843ce9d2d0599c3e3ce6d59c1551f

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID26419 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID26420 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID116554

Total number of triples: 69.